1. Search

Search Results for 'stem cell product'

1 results found.

REMEDI enters agreement with US company to advance research into diabetic foot ulcers

Galway Advertiser / NewsThu, Aug 08, 2013

REMEDI, The Regenerative Medicine Institute at NUI Galway and Orbsen Therapeutics have entered into an agreement with Cardium Therapeutics to utilise Cardium’s Excellagen® pharmaceutically-formulated gel as a delivery agent for Orbsen Therapeutics’ proprietary stromal cell therapy in pre-clinical studies for the potential treatment of diabetic foot ulcers.

 
Advertiser.ie
Contact
Place an Ad
Terms & Conditions
Privacy Policy

© 2024 Advertiser.ie
Galway Advertiser is a member of Free Media Ireland, a network of free newspaper publishers committed to supporting local journalism and delivering engaging content while providing highly effective print advertising with unparalleled circulations. Visit https://freemediaireland.ie to learn more.

This publication supports the work of the Press Council of Ireland and Office of the Press Ombudsman, and our staff operate within the Code of Practice of the Press Council.
You can obtain a copy of the Code of Practice, or contact the Press Council, at 01-6489130, email [email protected].

Page generated in 0.0454 seconds.